サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765170

腎除神経技術の世界市場

Renal Denervation Technologies

出版日
ページ情報
英文 107 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.69円
腎除神経技術の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 107 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腎除神経技術の世界市場は2030年までに31億米ドルに達する見込み

2024年に3億7,830万米ドルと推定される腎除神経技術の世界市場は、2024-2030年の分析期間でCAGR 41.7%の成長を遂げ、2030年には31億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである高周波ベースは、CAGR 41.3％を記録し、分析期間終了までに21億米ドルに達すると予測されます。超音波ベースのセグメントは、分析期間のCAGRが43.5％と推定されます。

米国市場は9,040万米ドルと推定、中国はCAGR51.7％で成長予測

米国の腎除神経技術市場は、2024年に9,040万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億4,990万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは51.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に34.4%と38.0%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約38.4%で成長すると予測されています。

世界の腎除神経技術市場- 主要動向と促進要因まとめ

腎除神経技術は、複数の降圧薬を使用しているにもかかわらず高血圧がコントロールされない状態である抵抗性高血圧の治療において、有望な進歩です。この低侵襲手術では、カテーテルを用いた高周波または超音波エネルギーを用いて、腎臓につながる動脈の周囲にある腎神経を切除します。腎除神経は、これらの神経を通じて伝達される信号を遮断することで、交感神経系の活動を抑制し、血圧を下げることを目的としています。この手技は通常、局所麻酔下で行われ、大腿動脈からカテーテルを挿入し、腎動脈まで誘導し、そこで標的アブレーションを行う。この手技は血圧を下げるだけでなく、持続的な効果をもたらす可能性を示しており、従来の治療法では十分な効果が得られない患者にとって魅力的な選択肢となっています。

技術の進歩により、腎除神経術の有効性と安全性は著しく向上しました。初期の臨床試験は一貫した結果が得られないという課題に直面し、技術のさらなる革新と改良を促しました。最新のシステムでは、カテーテルの設計が改良され、より優れたナビゲーションとエネルギー照射の精度が提供されるようになり、周辺組織へのダメージを最小限に抑え、患者の予後を向上させています。さらに、画像診断とマッピング技術の進歩により、腎神経をより正確に狙い撃ちできるようになり、効果的なアブレーションが可能になりました。また、超音波や化学的アブレーションなど、高周波を用いない方法への関心も高まっており、独自の利点を持つ代替アプローチが提供されています。絶え間ない研究開発により、高血圧の根底にある生理学的メカニズムに対する理解が深まり、より効果的で個人に合った腎除神経戦略が確立されつつあります。

腎除神経技術市場の成長は、いくつかの要因によって牽引されています。世界の高血圧の有病率の増加、特に耐性高血圧は、革新的な治療オプションに対する需要を煽るため、主要な促進要因となっています。医療技術の開発と高血圧の病態生理の深い理解が、より効果的で安全な腎除神経システムの開発につながっています。世界人口の高齢化は、食生活の乱れや座りがちな生活といったライフスタイルの要因と相まって、高血圧の罹患率上昇の一因となっており、こうした技術の潜在的市場はさらに拡大しています。さらに、腎除神経の長期的な特典と安全性を支持する臨床エビデンスの蓄積は、より多くの医療提供者にこの治療法の採用を促しています。回復期間が短く合併症の少ない治療に対する患者の嗜好に後押しされ、現代医療において低侵襲治療が推進されていることも、市場の成長を支えています。これらの要因が相まって、腎除神経技術市場のダイナミックかつ急速な進化が浮き彫りになっています。

セグメント

技術（高周波ベース、超音波ベース、マイクロインフュージョンベース）

調査対象企業の例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第4章 競合

目次
Product Code: MCP14407

Global Renal Denervation Technologies Market to Reach US$3.1 Billion by 2030

The global market for Renal Denervation Technologies estimated at US$378.3 Million in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Ultrasound Based segment is estimated at 43.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$90.4 Million While China is Forecast to Grow at 51.7% CAGR

The Renal Denervation Technologies market in the U.S. is estimated at US$90.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$249.9 Million by the year 2030 trailing a CAGR of 51.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 34.4% and 38.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 38.4% CAGR.

Global Renal Denervation Technologies Market - Key Trends & Drivers Summarized

Renal denervation technologies represent a promising advancement in the treatment of resistant hypertension, a condition where high blood pressure remains uncontrolled despite the use of multiple antihypertensive medications. This minimally invasive procedure involves the use of catheter-based radiofrequency or ultrasound energy to ablate the renal nerves, which are located around the arteries leading to the kidneys. By disrupting the signals transmitted through these nerves, renal denervation aims to reduce sympathetic nervous system activity, thereby lowering blood pressure. The procedure is typically performed under local anesthesia and involves the insertion of a catheter through the femoral artery, guided to the renal arteries, where targeted ablation is conducted. The technique has shown potential not only in reducing blood pressure but also in offering sustained effects, making it an attractive option for patients who do not respond adequately to conventional therapies.

Technological advancements have significantly enhanced the efficacy and safety of renal denervation procedures. Early clinical trials faced challenges with inconsistent results, prompting further innovation and refinement in the technology. Modern systems now offer improved catheter designs with better navigability and precision in delivering energy, which minimizes damage to surrounding tissues and enhances patient outcomes. Additionally, advancements in imaging and mapping technologies allow for more accurate targeting of the renal nerves, ensuring effective ablation. There has also been a growing interest in non-radiofrequency methods, such as ultrasound and chemical ablation, which provide alternative approaches with their own unique benefits. Continuous research and development are expanding the understanding of the physiological mechanisms underlying hypertension, leading to more effective and tailored renal denervation strategies.

The growth in the renal denervation technologies market is driven by several factors. The increasing prevalence of hypertension worldwide, particularly resistant hypertension, is a major driver, as it fuels the demand for innovative treatment options. Advances in medical technology and a deeper understanding of the pathophysiology of hypertension have led to the development of more effective and safer renal denervation systems. The aging global population, coupled with lifestyle factors such as poor diet and sedentary behavior, contributes to the rising incidence of hypertension, further expanding the potential market for these technologies. Additionally, the growing body of clinical evidence supporting the long-term benefits and safety of renal denervation is encouraging more healthcare providers to adopt this treatment modality. The push for minimally invasive procedures in modern medicine, driven by patient preference for treatments with shorter recovery times and fewer complications, also supports market growth. These factors collectively highlight the dynamic and rapidly evolving nature of the renal denervation technologies market.

SCOPE OF STUDY:

The report analyzes the Renal Denervation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Radiofrequency Based, Ultrasound Based, Micro-Infusion Based)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Renal Denervation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Hypertension - A Chronic Disease
    • A Prelude to Renal Denervation
    • The Evolution
    • Global Renal Denervation Technologies Market Set to Witness Rapid Growth
    • Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
    • Europe - A Major Market
    • Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
    • Radiofrequency Based Renal Denervation
    • Ultrasound Based Renal Denervation
    • Micro-Infusion Based Renal Denervation
    • Stringent Regulatory Environment
    • Growth Deterrents
    • Competitive Landscape
    • Select List of Approved Renal Denervation Devices
    • Symplicity Renal Denervation System Leads
    • Renal Denervation Devices
    • EnligHTN
    • Iberis
    • Paradise
    • Symplicity
    • Vessix (V2)
    • Recent Market Activity
    • Recent Clinical Trials in Nerve Denervation Technologies
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Ageing Demographics to Propel the Demand for Renal Denervation Devices
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • Regulatory Approvals to Remain a Focal Point
    • Breakthrough Designations for Renal Denervation Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 9: World Renal Denervation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 10: USA Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 11: USA 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CANADA
    • TABLE 12: Canada Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 13: Canada 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • JAPAN
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 14: Japan Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Japan 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CHINA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 16: China Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: China 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • EUROPE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: Europe 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • FRANCE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 22: France Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: France 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • GERMANY
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 24: Germany Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Germany 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ITALY
    • TABLE 26: Italy Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Italy 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • UNITED KINGDOM
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 28: UK Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: UK 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • SPAIN
    • TABLE 30: Spain Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Spain 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • RUSSIA
    • TABLE 32: Russia Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Russia 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • LATIN AMERICA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 38: Latin America Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Latin America 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 40: Rest of World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Rest of World 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030

IV. COMPETITION